Related Experiment Video
Updated: Apr 24, 2026

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
Published on: March 3, 2023
Nicotine dependence among critically ill COVID-19 patients: A population-based cohort study
John Garza1, Roy Sebastian1, Brinkley Cover1
1Texas Tech University Health Sciences Center at the Permian Basin, Odessa, Texas, United States of America.
None:
Nicotine dependence is associated with lower life expectancy and patients who use nicotine are at an increased risk of diseases of the respiratory system. Data on the prognostic impact of nicotine dependence in COVID-19 is inconclusive. We used publicly available, statewide, and deidentified records to study hospitalizations of patients aged ≥ 18 years with a principal diagnosis of COVID-19 admitted to the intensive care units of acute care hospitals in Texas from Q2 2020 through Q4 2024. We measured the effect of nicotine dependence on mortality in the overlap population using weighted multivariable logistic regression and g-computation. We identified 142,045 hospitalizations admitted to intensive care units with a principal diagnosis of COVID-19 of which 10,452 (7.3%) were classified as currently nicotine dependent, 23,671 (16.7%) as formerly nicotine dependent, and 107,922 (76.0%) as never nicotine dependent. Currently and formerly nicotine dependent individuals had significantly higher burden of comorbidities compared to never nicotine dependent individuals; mean [standard deviation] Deyo comorbidity index 1.8 [1.9] and 1.8 [1.9] vs 1.4 [1.8] but lower rates of in-hospital mortality 10.7% and 13.8% vs 16.1%. On adjusted analysis, current nicotine dependence and former nicotine dependence remained associated with reduced in-hospital and short-term mortality. Additional investigations exploring the mechanisms leading to these findings are necessary.
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
CNS Depressants: Alcohol and Nicotine
Drug Dependence
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

